EUVIMEDEUVIMED entdecken
LeitlinieQuerschnittstudie

Concordance between treatment guideline and daily practice in the management of eosinophilic granulomatosis with polyangiitis: a cross-sectional web-questionnaire survey

Ryu Watanabe iD, Takao Fujii, Yoshia Miyawaki, Haruki Koike, Masashi Bando, Motomu Hashimoto, Naoto Tamura

Modern Rheumatology · 22.12.2025 · 36 (1) · 68-76

DOI: 10.1093/mr/roaf064 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Modern Rheumatology, online erschienen am 08.07.2025. Verfasst von Ryu Watanabe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Practice Patterns, Physicians', Glucocorticoids, Granulomatosis with Polyangiitis, Immunosuppressive Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Japan Research Committee of the Ministry of Health, Labour and Welfare for Intractable Vasculitis from the Ministry of Health, Labour and Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To examine real-world clinical practices in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) across Japan and evaluate concordance with national treatment guidelines.

Methods

A cross-sectional, web-based survey was conducted between 14 and 19 February 2024. Physicians from rheumatology, pulmonology, and neurology departments who had treated EGPA within the past 24 months were invited to complete a 17-item questionnaire. The survey assessed actual prescribing behaviour, future treatment preferences, responses to two clinical scenarios, and the frequency of guideline use.

Results

Among 220 respondents (110 rheumatologists, 55 neurologists, and 55 pulmonologists), cyclophosphamide (77.3%) and mepolizumab (73.2%) were frequently used with glucocorticoids (GCs) for remission induction. GC monotherapy was the most commonly selected option overall (31.4%), but its use decreased to 14.8% for severe cases. GC + mepolizumab was the most frequently selected regimen for both maintenance and relapse. Responses to clinical scenarios revealed partial divergence from guideline-based recommendations, particularly regarding the limited use of immunosuppressants and the preferential use of mepolizumab.

Conclusions

This study identified a modest but clear evidence–practice gap in EGPA management in Japan. Broader dissemination of updated guidelines and enhanced interdisciplinary collaboration may help align clinical practice with evidence-based standards and improve patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Patterns, Physicians'GlucocorticoidsGranulomatosis with PolyangiitisImmunosuppressive AgentsGuideline AdherenceChurg-Strauss SyndromeHumansCross-Sectional StudiesJapanSurveys and QuestionnairesPractice Guidelines as TopicAntibodies, Monoclonal, HumanizedCyclophosphamideMaleFemaleMiddle Aged

Stichwörter der Autor:innen

ANCA-associated vasculitiseosinophilic granulomatosis with polyangiitisevidence–practice gapimmunosuppressants

Substanzen

mepolizumabGlucocorticoidsImmunosuppressive AgentsAntibodies, Monoclonal, HumanizedCyclophosphamide

Autor:innen und Institutionen

  • Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan.
  • Department of Nephrology, Rheumatology, Endocrinology, and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Neurology, Saga University, Saga, Japan.
  • Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.

ORCID-Profile: Ryu Watanabe

Förderung

  • Japan Research Committee of the Ministry of Health, Labour and Welfare for Intractable Vasculitis from the Ministry of Health, Labour and Welfare of Japan

Zitieren

APA

Watanabe, R., Fujii, T., Miyawaki, Y., Koike, H., Bando, M., Hashimoto, M., & Tamura, N. (2025). Concordance between treatment guideline and daily practice in the management of eosinophilic granulomatosis with polyangiitis: a cross-sectional web-questionnaire survey. Modern Rheumatology, 36(1), 68-76. https://doi.org/10.1093/mr/roaf064

Vancouver

Watanabe R, Fujii T, Miyawaki Y, Koike H, Bando M, Hashimoto M, et al. Concordance between treatment guideline and daily practice in the management of eosinophilic granulomatosis with polyangiitis: a cross-sectional web-questionnaire survey. Modern Rheumatology. 2025;36(1):68-76. doi:10.1093/mr/roaf064

BibTeX
@article{Watanabe2025,
  author = {Watanabe, Ryu and Fujii, Takao and Miyawaki, Yoshia and Koike, Haruki and Bando, Masashi and Hashimoto, Motomu and Tamura, Naoto},
  title = {Concordance between treatment guideline and daily practice in the management of eosinophilic granulomatosis with polyangiitis: a cross-sectional web-questionnaire survey},
  journal = {Modern Rheumatology},
  year = {2025},
  volume = {36},
  number = {1},
  pages = {68--76},
  doi = {10.1093/mr/roaf064}
}
Kostenlos starten →